Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids
- PMID: 29676183
- DOI: 10.4155/fmc-2017-0293
Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids
Abstract
Aim: The research of novel and potent antidiabetic agents is urgently needed for the control of the exploding diabetic population. We previously reported the synthesis and antidiabetic activity of natural 8-(6"-umbelliferyl)-apigenin (1), but its antidiabetic targets are not known. Therefore, four series of derivatives were synthesized and evaluated for their antidiabetic activities. Results & methodology: Compounds (5a) and (14a) were identified as new α-glucosidase and α-amylase dual inhibitors. The kinetic analysis of the most potent α-glucosidase inhibitor of each series of compounds revealed that they inhibited α-glucosidase in irreversible modes. In addition, compounds (5a) and (14a) showed potent glucose consumption-promoting activity.
Conclusion: Compounds (5a) and (14a) could be regarded as promising starting points for the development of antidiabetic candidates.
Keywords: 8-(6”-umbelliferyl)-apigenin; antidiabetes; coumarins; flavonoid; hybrids; α-glucosidase.
Similar articles
-
Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies.Bioorg Chem. 2019 Nov;92:103206. doi: 10.1016/j.bioorg.2019.103206. Epub 2019 Aug 16. Bioorg Chem. 2019. PMID: 31445191
-
α-Glucosidase and α-Amylase Inhibitors from Arcytophyllum thymifolium.J Nat Prod. 2016 Aug 26;79(8):2104-12. doi: 10.1021/acs.jnatprod.6b00484. Epub 2016 Aug 10. J Nat Prod. 2016. PMID: 27509358
-
Coumarin-based Scaffold as α-glucosidase Inhibitory Activity: Implication for the Development of Potent Antidiabetic Agents.Mini Rev Med Chem. 2020;20(2):134-151. doi: 10.2174/1389557519666190925162536. Mini Rev Med Chem. 2020. PMID: 31553294 Review.
-
Multicomponent reaction for the synthesis of new 1,3,4-thiadiazole-thiazolidine-4-one molecular hybrids as promising antidiabetic agents through α-glucosidase and α-amylase inhibition.Bioorg Chem. 2021 Oct;115:105210. doi: 10.1016/j.bioorg.2021.105210. Epub 2021 Jul 26. Bioorg Chem. 2021. PMID: 34332231
-
An insight on medicinal attributes of 1,2,3- and 1,2,4-triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors.Mol Divers. 2024 Oct;28(5):3605-3634. doi: 10.1007/s11030-023-10728-1. Epub 2023 Sep 21. Mol Divers. 2024. PMID: 37733243 Review.
Cited by
-
Discovery of New α-Glucosidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation.Front Chem. 2021 Mar 8;9:639279. doi: 10.3389/fchem.2021.639279. eCollection 2021. Front Chem. 2021. PMID: 33763406 Free PMC article.
-
Effects of Bacillus cereus and coumarin on growth performance, blood biochemical parameters, and meat quality in broilers.Vet World. 2020 Nov;13(11):2484-2492. doi: 10.14202/vetworld.2020.2484-2492. Epub 2020 Nov 23. Vet World. 2020. PMID: 33363345 Free PMC article.
-
Innovation of 6-sulfonamide-2H-chromene derivatives as antidiabetic agents targeting α-amylase, α-glycosidase, and PPAR-γ inhibitors with in silico molecular docking simulation.RSC Adv. 2024 May 14;14(22):15691-15705. doi: 10.1039/d4ra02143f. eCollection 2024 May 10. RSC Adv. 2024. PMID: 38746843 Free PMC article.
-
Discovery of novel flavonoid derivatives as potential dual inhibitors against α-glucosidase and α-amylase: virtual screening, synthesis, and biological evaluation.Mol Divers. 2024 Jun;28(3):1629-1650. doi: 10.1007/s11030-023-10680-0. Epub 2023 Jun 27. Mol Divers. 2024. PMID: 37369956
-
Flavonoids as dual-target inhibitors against α-glucosidase and α-amylase: a systematic review of in vitro studies.Nat Prod Bioprospect. 2024 Jan 8;14(1):4. doi: 10.1007/s13659-023-00424-w. Nat Prod Bioprospect. 2024. PMID: 38185713 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources